Sebia to acquire a minority stake in Metafora biosystems.
Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD
Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.
The strategic acquisition reinforces Sebia’s global leadership in specialty diagnostics.
Educational Webinar with Dr. Annette BOWYER, Lead Biomedical Scientist
Educational Webinar with M. Jean Deenmamode, IFCC Working Group Chair